NCT01911624View on ClinicalTrials.gov

Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia

PHASE2CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

July 31, 2016

Conditions
Staphylococcus Aureus Bacteraemia
Interventions
DRUG

direct thrombin inhibition

DRUG

enoxaparin

Trial Locations (1)

3000

KUleuven/UZ Gasthuisberg, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT01911624 - Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia | Biotech Hunter | Biotech Hunter